Lv, X.; Song, Y.; Liu, T.; Zhang, D.; Ye, X.; Wang, Q.; Li, R.; Chen, J.; Zhang, S.; Yu, X.;
et al. Ginsenoside Rg3 Adjunctively Increases the Efficacy of Gefitinib Against NSCLC by Regulating EGFR Copy Number. Pharmaceuticals 2025, 18, 1077.
https://doi.org/10.3390/ph18071077
AMA Style
Lv X, Song Y, Liu T, Zhang D, Ye X, Wang Q, Li R, Chen J, Zhang S, Yu X,
et al. Ginsenoside Rg3 Adjunctively Increases the Efficacy of Gefitinib Against NSCLC by Regulating EGFR Copy Number. Pharmaceuticals. 2025; 18(7):1077.
https://doi.org/10.3390/ph18071077
Chicago/Turabian Style
Lv, Xinyi, Yuehan Song, Tianhua Liu, Dingdan Zhang, Xinpeng Ye, Qingqing Wang, Rongrong Li, Jiayi Chen, Shujing Zhang, Xue Yu,
and et al. 2025. "Ginsenoside Rg3 Adjunctively Increases the Efficacy of Gefitinib Against NSCLC by Regulating EGFR Copy Number" Pharmaceuticals 18, no. 7: 1077.
https://doi.org/10.3390/ph18071077
APA Style
Lv, X., Song, Y., Liu, T., Zhang, D., Ye, X., Wang, Q., Li, R., Chen, J., Zhang, S., Yu, X., & Hou, C.
(2025). Ginsenoside Rg3 Adjunctively Increases the Efficacy of Gefitinib Against NSCLC by Regulating EGFR Copy Number. Pharmaceuticals, 18(7), 1077.
https://doi.org/10.3390/ph18071077